Study of Schistosoma mansoni Isolates from Patients with Failure of Treatment with Oxamniquine

Memorias do Instituto Oswaldo Cruz

Volumn 95, Issue 3, 2000, Pages 375-380

  Conceição, Maria José ^a   Argento, Carlos Alberto ^a   Corrêa, Acyr ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Failure of treatment; Oxamniquine; Patients; Schistosoma mansoni

Indexed keywords

SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

ANTISCHISTOSOMAL AGENT; OXAMNIQUINE;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; DRUG RESISTANCE; FEMALE; HUMAN; MALE; MOUSE; SCHISTOSOMA MANSONI; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANIMALS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MICE; OXAMNIQUINE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDES; TREATMENT FAILURE;

EID: 0034185615     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762000000300013     Document Type: Article

References (42)

1. Andrade ZA 1998. The situation of hepatosplenic schistosomiasis in Brazil today. Mem Inst Oswaldo Cruz 93: 313-316.
2. Araújo N, Katz N, Dias CP, Souza CP 1980. Susceptibility of chemotherapeutic agents of strains of Schistosoma mansoni, isolated from treated and untreated patients. Am J Trop Med Hyg 29: 890-894.
3. Barbosa FAS 1966. Morbidade da esquistossomose. Rev Bras Malariol D Trop, Special issue: 3-153.
4. Bina JC 1977. Influência da Terapêutica Específica na Evolução da Esquistossomose, MSc Thesis, Universidade Federal da Bahia, Salvador, 58 pp.
5. Bina JC 1995. Estudo das Variáveis que Podem Influenciar na Evolução da Esquistossomose Mansônica: Efeito da Terapêutica Específica e da Interrupção da Transmissão, PhD Thesis, Universidade Federal da Bahia, Salvador, 126 pp.
6. Bruce JL, Dias LCS, Liang Y, Coles GC 1987. Drug resistance in schistosomiasis: A review. Mem Inst Oswaldo Cruz 82 (Suppl. IV): 143-150.
7. Chaia G 1956.Técnica para concentração de miracídios. Rev Bras Malariol D Trop 8: 355-377.
8. Cioli D, Pica-Mattoccia L, Archer S 1989. Resistance of schistosomes to hycanthone and oxamniquine. Mem Inst Oswaldo Cruz 84 (Suppl. I): 38-44.
9. Cioli D, Pica-Mattoccia L, Moroni R 1992. Hycanthone/ Oxamniquine resistance is controlled by a single autosomal recessive gene. Exp Parasitol 75: 425-432.
10. Clarke VV, Blair DM, Weber MC, Garnett PA 1976. Dose-finding trials of oral oxamniquine in Rhodesia. South Af Med J 50: 1867-1871.
11. Coelho PMZ, Ribeiro F, Mello RT, Silva FCL, Nogueira-Machado JA 1998. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase. Mem Inst Oswaldo Cruz 93 (Suppl. I): 267-268.
12. Coelho PMZ, Silva ECL, Nogueira-Machado JÁ 1997. Resistance to oxamniquine of a Schistosma mansoni strain isolated from patient submitted to repeated treatments. Rev Inst Med Trop S Paulo 39 : 101-106
13. Coles GC, Mutahi WT, Kinoti GK, Bruce J I, Katz N 1987. Tolerance of Kenyan Schistosoma mansoni to oxamniquine. Trans R Soc Trop Med Hyg 81: 782-785.
14. Conceição MJ, Coura J R 1986. Comportamento experimental de amostras de Schistosoma mansoni em relação às formas clínicas de esquistossomose. I. Estudo em camundongos. Mem Inst Oswaldo Cruz 81: 61-66.
15. Conceição MJ, Argento CA, Moura DC, Silva SC 1997. Estudo experimental de isolados de Schistosoma mansoni de pacientes que não obtiveram cura com a oxamniquine. Rev Soc Bras Med Trop 30: 117.
16. Conceição MJ, Argento CA, Teixeira A 1995. Tolerance to oxamniquine in Schistosoma mansoni infected patients. Abstracts International Conference on Schistosomiasis, Cairo, Egypt, p. 167.
17. Dias LCS, Pedro RJ, Duberaldine ER 1982. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or/ hycanthone of Schistosoma mansoni to schistosomicidal agents. Trans R Soc Trop Med Hyg 76: 652-659.
18. Dias LCS, Pedro RJ, Rigo E, Goto MF, Mafra GK 1978 Linhagem humana de Schistosoma mansoni resistente a esquistosomicidas. Rev Saúde Pública 12: 110.
19. Doenhoff M J 1987. The immune dependence of chemotherapy in experimental schistosomiasis. Mem Inst Oswaldo Cruz 84 (Suppl. I): 31-37.
20. Doenhoff MJ, Bain J 1978. The immune-dependence of schistosomiasis chemotherapy relative lack of efficacy of an antimonial in Schistosoma mansoni-infected mice deprived of their T-cells and the demonstration of drug- antiserum synergy. Clin Exp Immununol 33: 232-238.
21. Doenhoff M J, Sabah AAA, Fletcher C, Webbe G, Bain J 1987. Evidence for an immuno-dependent action of praziquantel on Schistosoma mansoni in mice. Trans R Soc Trop Med Hyg 81: 947-951.
22. Drescher KM Rogers EJ, Bruce JI, Katz N, Dias LCS, Coles G 1993. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents. Mem Inst Oswaldo Cruz 88: 89-95.
23. Foster R 1987. A review of clinical experience with oxamniquine. Trans R Soc Trop Med Hyg 81: 55-59.
24. Foster R, Cheetam BL 1973. Studies with schistosomicide oxamniquine (UK-427A). I. Activity in rodents and in vitro. Trans R Soc Trop Med Hyg 67: 674-684.
25. Foster R, Cheetam RL, King DF, Mesmer ET 1971a. The action of UK 3883, a novel, 2-amino-methyltetrahydroquinoline derivative, against mature schistosomes in rodents and primates. Ann Trop Med Parasitol 65: 59-70.
26. Foster R, Cheetam RL, Mesmer ET, King DF 1971b. Comparative studies of the action of mirasan, lucanthone, hycanthone and niridazole against Schistosoma mansoni in mice. Ann Trop Med Parasitol 65: 45-58.
27. Hillman GR, Senft AW 1975. Anticholinergic properties of the antischistosomal drug hycanthone. Am J Trop Med Hyg 24: 827-834.
28. Ismail M, Attia MM, Metwally AA, Farghaly AM, Bruce J, Benett J, Tao LF 1995. Praziquantel resistance to schistosomiasis mansoni in Egypt II - Response of Schistosoma mansoni isolates to different doses of praziquantel. Abstracts International Conference on Schistosomiasis, Cairo, Egypt, p. 166.
29. Jansma WB, Rogers SH, Liu CL, Bueding E 1977. Experimentally produced resistance to Schistosoma mansoni to hycanthone. Am J Trop Med Hyg 26: 926-936.
30. Kato K 1960. A correct application of the thick-smear technique with cellophane paper cover. A pamphlet 9 pp. In Y Komyia & A Kobayashi, An evaluation of Kato Thick-smear. Jap J Med Sci Biol 19: 59-64.
31. Katz N 1980. Resultados atuais na terapêutica clínica da esquistossomose mansoni. Rev Inst Med Trop S Paulo 22 (Suppl. IV): 123-133.
32. Katz N, Chaves A, Pellegrino J 1972. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop S Paulo 14: 397-400.
33. Katz N, Dias P, Araujo N, Souza CP 1973. Estudo de uma cepa de Schistosoma mansoni resistente a agentes esquistossomicidas. Rev Soc Bras Med Trop 7: 381-387.
34. Kemp HÁ, Hunter GW, Wilkin OP, Smalley H, Dashell MA 1956. Some ointments examined for protection against Schistosoma mansoni cercariae in preliminary tests. Militar Medicine 119: 1-10.
35. Kinoti GK 1987. The significance of variantion in the susceptibility of Schistosoma mansoni to the antischistosomal drug oxamniquine. Mem Inst Oswaldo Cruz 82 (Supl. IV) : 151-156.
36. Lambertucci JR, Greco DB, Pedroso ERP, Rocha MOC, Salazar HM, Lima DP 1990. Double blind trial with oxamniquine in chronic schistosomiasis mansoni. Trans R Soc Trop Med Hyg 76: 751-755.
37. Meang FSW, Marshal I, Higgins M 1987. Oxamniquine resistance in S. mansoni. Fact or fiction? Am J Trop Med Parasitol 81: 337-339.
38. Pellegrino J, Katz N 1972. Experimental chemotherapy of schistosomiasis. V - Laboratory trials with UK 3883, a 2- aminomethyltetrahydroquinoline derivative. Rev Inst Med Trop S Paulo 14: 59-66.
39. Pessoa SB, Barros PR 1953. Notas sobre a epidemiologia da esquistossomose mansônica no Estado de Sergipe. Rev Med Cir São Paulo 13: 147-154.
40. Pica-Mattoccia L, Cioli D 1985. Studies on the mode of action of oxamniquine and related schistosomicidal drugs. Am J Trop Med Hyg 34: 112-118.
41. Pica-Mattoccia L, Dias LCS, Archer S 1989. Binding of oxamniquine to the DNA of schistosomes. Trans R Soc Trop Med Hyg 83: 89-96.
42. Radke MG, Berrios-Duran LA, Morab K 1961. A perfusion procedure (Perf-o-suction) for recovery of Schistosoma mansoni. J Parasitol 47: 366-368.